Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (701-710 of 850) with videos related to

Pageof 85
Sort By:
Cancers|March 10, 2022
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical CystectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancerMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
International Journal of Cancer|October 13, 2017
Summary statement on screening for prostate cancer in EuropeEveline A M Heijnsdijk, Chris H Bangma, Josep M Borràs, et al.
Surgical Oncology|March 22, 2023
Regional differences in total hospital costs for radical cystectomy in the United StatesBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Arab Journal of Urology|July 31, 2023
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Surgical Oncology|May 23, 2022
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Pageof 85

Showing results (701-710 of 850) with videos related to

Sort By:
Pageof 85
Cancers|March 10, 2022
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical CystectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancerMarkus Graefen, Pierre I Karakiewicz, Ilias Cagiannos, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
Pathology International|August 11, 2020
High B7-H3 expression is linked to increased risk of prostate cancer progressionSarah Bonk, Pinar Tasdelen, Martina Kluth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
International Journal of Cancer|October 13, 2017
Summary statement on screening for prostate cancer in EuropeEveline A M Heijnsdijk, Chris H Bangma, Josep M Borràs, et al.
Surgical Oncology|March 22, 2023
Regional differences in total hospital costs for radical cystectomy in the United StatesBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Arab Journal of Urology|July 31, 2023
Racial/ethnic disparities in the distribution and effect of type and number of high-risk criteria on mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2021
Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate CancerDoris Höflmayer, Christoph Fraune, Claudia Hube-Magg, et al.
Surgical Oncology|May 23, 2022
Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Pageof 85